Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

April 12, 2023

Study Completion Date

April 12, 2023

Conditions
Nail Diseases
Interventions
DEVICE

Platelet-rich plasma

Blood will be drawn from a vein in the patient's arm into an 11 ml Eclipse platelet-rich plasma Tube. The blood is processed using a centrifuge machine from eclipse medical. After centrifugation, the platelet poor portion will be separated from the platelet-rich portion. The proximal nail folds are cleansed with alcohol. Using a 1ml syringe and 30g needle, 0.1-0.2 ml of platelet-rich plasma is injected into 8 proximal nail folds.

DEVICE

Platelet-poor plasma

Blood will be drawn from a vein in the patient's arm into an 11 ml Eclipse platelet-rich plasma Tube. The blood is processed using a centrifuge machine from eclipse medical. After centrifugation, the platelet poor portion will be separated from the platelet-rich portion. The proximal nail folds are cleansed with alcohol. Using a 1ml syringe and 30g needle, 0.1-0.2 ml of platelet-poor plasma is injected into 2 proximal nail folds.

Trial Locations (1)

10021

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

Eclipse Aesthetics, LLC

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT04941807 - Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome | Biotech Hunter | Biotech Hunter